ET
Endlyz Therapeutics, Inc.
SEC filingOther · Boston, MA
Amount raised$17.3Msold at filing
Total offering$19.7M$2.4M still open
Investors in the raise7count reported to the SEC
FiledMay 7, 2026first sale Mar 31, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Justian Craig FoxDirector
Donmienne LeungDirector
Laurence BarkerDirector
Timothy EdwardsDirector
Joanna WolakExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.